SURO

Suro Capital Corp. is a publicly traded business development company (BDC) that specializes in investing in high-growth, venture-backed companies. While not a traditional biotechnology company, Suro Capital maintains a significant focus on the life sciences and healthcare sectors as part of its broader technology-driven investment strategy. The firm provides retail and institutional investors with access to late-stage private companies that are typically reserved for institutional venture capital. Its portfolio has historically included notable names in digital health, biotechnology, and educational technology, aiming to capitalize on the transition of these companies toward public markets.